Sonoma Pharmaceuticals Inc (SNOA) financials · rev $19.5M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Sonoma Pharmaceuticals Inc (SNOA) rev $19.5M.
| Line | FY2026 | FY2025 |
|---|---|---|
| Revenue | $19.5M | $14.3M |
| Cost of Revenue | $12.1M | $8.82M |
| Gross Profit | $7.42M | $5.46M |
| Operating Income | -$2.46M | -$3.71M |
| Net Income | -$3.17M | -$3.46M |
| EPS (Diluted) | -$1.89 | -$2.79 |
| Line | FY2026 | FY2025 |
|---|---|---|
| Total Assets | $14.0M | $13.7M |
| Current Assets | $12.1M | $12.6M |
| Cash & Equivalents | $2.40M | $5.37M |
| Inventory | $3.65M | $2.92M |
| PP&E | $310.0K | $225.0K |
| Total Liabilities | $10.9M | $9.28M |
| Current Liabilities | $4.83M | $4.10M |
| Short-term Debt | $222.0K | $220.0K |
| Total Debt | $222.0K† | $220.0K† |
| Shareholders' Equity | $3.10M | $4.41M |
| Retained Earnings | -$201.0M | -$197.8M |
† Total Debt: Derived from short-term debt only (no total or long-term debt stored).
| Line | FY2026 | FY2025 |
|---|---|---|
| Operating Cash Flow | -$3.93M | -$88.0K |
| CapEx | $192.0K | $80.0K |
| Investing Cash Flow | -$192.0K | -$80.0K |
| Financing Cash Flow | $477.0K | $3.03M |
| Net Change in Cash | -$2.98M | $2.25M |
| Free Cash Flow | -$4.13M | -$168.0K |
FAQ
What is SNOA P/E and revenue?
Sonoma Pharmaceuticals Inc (SNOA) rev $19.5M.
What is SNOA revenue?
Sonoma Pharmaceuticals Inc last cached revenue is $19.5M (FY2026).
Is SNOA profitable?
Sonoma Pharmaceuticals Inc last cached net income is -$3.17M (FY2026).
What are SNOA total assets?
Sonoma Pharmaceuticals Inc last cached total assets are $14.0M (FY2026).
What is SNOA free cash flow?
Sonoma Pharmaceuticals Inc last cached free cash flow is -$4.13M (FY2026).
Not investment advice. Cached statements, not a live tape.